However, a striking difference in the tumour size was noted, when comparing the Utt-B- and the sorafenib-treated mice, suggesting that Utt-B displays an upper hand in the destruction of HCC cells (Figure 1M,N). This evidence concerns the gene PPIB and neoplasm.